Abbvie Inc (NYSE:ABBV) currently has a daily average trading volume of 5.54M but it saw 5723104 shares traded in last market. With a market cap of 313.55B USD, the company’s current market price of $177.50 came rising about 0.70 while comparing to the previous closing price of $176.27. In past 52 weeks, the stock remained buoying in the range of price level as high as $182.89 and as low as $130.96.
Taking a look at 20-day trading activity of Abbvie Inc (ABBV) gives us an average price of $178.85, while its current price level is -2.95% below from 52-week high level whereas it is 35.54% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $172.93 while that of 200 days or SMA-200 reads an average of $152.49. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.41% during that period while stretching the period over a month that increases to 1.63%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 51.69 which implies that the stock is in neutral territory.
Over the week, ABBV’s stock price is moving -2.04% down while it is 1.35% when we observe its performance for the past one month. Year-to-date it is 14.54% up and over the past year, the stock is showing an upside performance of 13.22%.
The latest quarterly earnings report issued by the company was for quarter ended 12/30/2023, when its quarterly earnings per share (EPS) of $2.79 beat the consensus estimate of $2.77 for the same. For ABBV, analysts are forecasting an EPS-growth rate of 0.70% for current year and estimate for EPS growth in next year is 9.10%. In next quarter, company is expected to be making quarterly sales of $13.52 billion as analysts are expecting the sales for current fiscal year at $54.54 billion and seeing the company making $57.9 billion in sales next year. Moreover, analysts are in estimates of $11.97 billion for current-quarter revenue.
Currently, Abbvie Inc’s total number of outstanding shares is 1.77B with 0.12% of that held by the insiders while 71.89% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 7.61% and return on equity (ROE) at 34.90%. It has a price to earnings ratio (P/E ratio) of 65.25 while having a 14.54 of forward P/E ratio. Stock’s beta reads 0.55. Stock has a price to book (P/B) ratio of 30.26 while price to sale or P/S ratio amounts to 5.77. Its return on asset (ROA) is 3.52% on average.
